相关实验视频
Updated: May 9, 2025

00:09
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
6.9K
RNA结合蛋白是癌症放射电阻的关键调节剂,也是预防瘤复发的潜在目标
Vasanth Kanth Thasma LoganathBabu1, Srisri Satishkartik1, Vanshikaa Karthikeyan1
1Department of Genetic Engineering, College of Engineering and Technology, SRM Institute of Science and Technology, Potheri, Kattankulathur, Chengalpattu, Tamilnadu, 603203, India.
Current radiopharmaceuticals
|April 30, 2025
概括
RNA结合蛋白 (RBPs) 是癌症的关键调节者. 本综述汇总了它们在电阻中的重要,但尚未研究的作用,为克服治疗障碍提供了洞察力.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- RNA结合蛋白 (RBPs) 在转录后控制基因表达,影响癌症.
- 放射电阻是癌症治疗的一个重大挑战,往往导致复发.
- RBPs,癌症干细胞 (CSC) 和治疗耐药性之间的相互作用是研究的一个新兴领域.
研究的目的:
- 审查和汇编目前对RNA结合蛋白在放射电阻中的作用的理解.
- 突出RBPs与抗辐射疗法的不足探索的联系.
- 提供关于RBPs作为克服放射电阻的潜在目标的最新视角.
主要方法:
- 文献综述和现有研究的综合.
- 对研究RBPs在癌症进展和治疗反应中的研究分析.
- 汇编了将RBP与放射电阻机制联系起来的证据.
主要成果:
- 通过CSC调节,RBPs与瘤进展,转移和化学抵抗的各个方面有关.
- 有证据表明,RBPs在放射电阻的发展中起着重要的作用,尽管研究不足.
- 特定的RBP可能会影响细胞对辐射的反应,影响治疗的疗效.
结论:
- RNA结合蛋白在癌症生物学和治疗耐药性方面发挥着至关重要的作用.
- 对RBPs的进一步研究对于理解和克服放射电阻至关重要.
- 向RBP可能提供新的策略,以提高癌症患者的放射治疗结果.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Negative Regulator Molecules
35.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Positive Regulator Molecules
105.5K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.5K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K

